GROTTELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.722
AS - Asia 1.114
EU - Europa 864
SA - Sud America 245
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 30
Totale 4.103
Nazione #
US - Stati Uniti d'America 1.640
SG - Singapore 535
BR - Brasile 195
IT - Italia 183
IE - Irlanda 178
CN - Cina 138
VN - Vietnam 133
HK - Hong Kong 125
RU - Federazione Russa 102
UA - Ucraina 89
DE - Germania 70
FR - Francia 55
FI - Finlandia 52
KR - Corea 44
GB - Regno Unito 32
CA - Canada 28
RO - Romania 22
BD - Bangladesh 21
IN - India 19
TR - Turchia 19
AR - Argentina 16
NL - Olanda 16
MX - Messico 14
BE - Belgio 13
JP - Giappone 11
LT - Lituania 11
PK - Pakistan 10
IQ - Iraq 9
ZA - Sudafrica 9
GT - Guatemala 8
AT - Austria 7
CO - Colombia 7
CR - Costa Rica 7
PL - Polonia 7
EC - Ecuador 6
SE - Svezia 6
TT - Trinidad e Tobago 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
IL - Israele 5
NP - Nepal 5
PE - Perù 5
SA - Arabia Saudita 5
SV - El Salvador 5
UZ - Uzbekistan 5
CH - Svizzera 4
CL - Cile 4
EU - Europa 4
ID - Indonesia 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ES - Italia 3
GP - Guadalupe 3
JM - Giamaica 3
MA - Marocco 3
NI - Nicaragua 3
BO - Bolivia 2
EG - Egitto 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
NG - Nigeria 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
OM - Oman 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 3.980
Città #
Singapore 400
Chandler 196
Dublin 178
San Jose 172
Ashburn 137
Hong Kong 123
Perugia 81
Council Bluffs 66
Santa Clara 65
San Mateo 64
Dong Ket 59
Boardman 50
Jacksonville 48
Moscow 43
Seoul 43
Beijing 37
Princeton 37
Lauterbourg 32
Medford 32
Ann Arbor 31
Munich 30
Ho Chi Minh City 27
Altamura 26
The Dalles 26
São Paulo 25
Wilmington 24
Dallas 23
Lawrence 23
New York 23
Bucharest 20
Turku 20
Andover 18
Falls Church 18
Hanoi 17
Los Angeles 15
Piscataway 13
Brooklyn 12
Brussels 12
Fremont 12
North Bergen 12
Phoenix 11
Amsterdam 10
Helsinki 10
Montreal 10
Chennai 9
Tokyo 9
Chicago 8
Des Moines 8
Rio de Janeiro 8
Atlanta 7
Baghdad 7
Frankfurt am Main 7
Johannesburg 7
Nuremberg 7
Curitiba 6
Guatemala City 6
Izmir 6
London 6
Norwalk 6
Orem 6
Redmond 6
Vilnius 6
Columbus 5
Da Nang 5
Milan 5
Redwood City 5
Saint Petersburg 5
San Francisco 5
San José 5
San Paolo di Civitate 5
Vicenza 5
Vienna 5
Warsaw 5
Ankara 4
Brno 4
Dearborn 4
Denver 4
Falkenstein 4
Houston 4
Las Vegas 4
Montefalco 4
Poplar 4
Belo Horizonte 3
Boston 3
Brasília 3
Brescia 3
Buffalo 3
Campinas 3
Campobasso 3
Can Tho 3
Caracas 3
City of London 3
Concord 3
Dammam 3
Fortaleza 3
Frankfurt Am Main 3
Harbin 3
Jinan 3
Kingston 3
Kuala Lumpur 3
Totale 2.601
Nome #
Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells 158
ALPHA-TOCOPHEROL SUCCINATE INHIBITS NF-KAPPA-B NUCLEAR TRANSLOCATION VIA NRF2 ACTIVATION THUS INDUCING A DETOXIFICATION RESPONSE AGAINST PRO-OXIDANT REDOX-CYCLING COMPOUNDS 152
Denervation does not Induce Muscle Atrophy Through Oxidative Stress 146
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-κB and Nrf2 signalling. 135
Adenosine A1 receptors contribute to mitochondrial vulnerability to pro-oxidant stressors 132
Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells 129
Cyclo (His-Pro) Protects SOD1G93A Microglial Cells from Paraquat Induced Toxicity 127
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up regulation of antioxidant defence. 124
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 124
2-Cl-adenosine: an antimetabolite in human prostate cancer PC3 cells. 123
Focus on cyclo(His-Pro): history and perspectives as antioxidant peptide. 123
Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity 120
Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation 118
A(1) and A(3) adenosine receptors alter glutathione status in an organ-specific manner and influence the changes after inhibition of gamma-glutamylcysteine ligase. 116
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase 111
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells. 110
Potential influence of cyclo(His-pro) on proteostasis: Impact on neurodegenerative diseases 106
Molecular and Cellular Studies Reveal Folding Defects of Human Ornithine Aminotransferase Variants Associated With Gyrate Atrophy of the Choroid and Retina 104
Dimerization drives proper folding of human alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 102
CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1 98
Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach 98
Peroxynitrite Activates the NLRP3 Inflammasome Cascade in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis 97
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence 96
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 93
Molecular Dynamics-Ensemble Docking and Biophysical Studies for Structure-Based Identification of Non-Amino Acidic Ligands of DDAH-1 92
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 91
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 91
ROS-independent Nrf2 activation in prostate cancer 89
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 87
Cyclo(His-Pro) alleviates LPS-induced neuroinflammation 86
The role of cyclo(His-Pro) in neurodegeneration 85
Impact of Enniatin and Deoxynivalenol Co-Occurrence on Plant, Microbial, Insect, Animal and Human Systems: Current Knowledge and Future Perspectives 84
Commensal fungi and oxalate degradation: is there a link? 78
Molecular events underlying antioxidant properties of cyclo(His-Pro) in PC12 cells 76
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 76
Erratum: Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signaling (Journal of Neurochemistry (2009) 111 (956-966)) 74
MITOCHONDRIAL EXPRESSION OF A1 ADENOSINE RECEPTOR EXACERBATES PRO-OXIDANT INJURY 72
Up-regulation of antioxidant defence by cyclo(His-Pro) through Nrf2 activation 65
Phosphoproteomic analysis of the effect of cyclo-(His-Pro)dipeptide on PC12 cells 60
Nanobodies as therapies for loss-of-function misfolding diseases: the example of Primary Hyperoxaluria Type 1 30
Towards modeling enteric hyperoxaluria in a tripartite microbiota-gut-kidney microphysiological system 25
Totale 4.103
Categoria #
all - tutte 18.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 0 0 0 14 8 9 83 19 28 33 44
2022/2023581 32 101 9 45 55 58 0 25 220 5 22 9
2023/2024250 22 23 12 3 1 1 44 10 24 7 48 55
2024/2025631 15 49 26 28 80 44 33 64 110 31 89 62
2025/20261.433 97 92 90 214 194 142 236 56 147 110 44 11
2026/2027455 33 45 82 250 45 0 0 0 0 0 0 0
Totale 4.103